Special Diabetes Program Reauthorization Act of 2019

Bill: 116-hr-2668
Sponsor: full_name: Rep. DeGette, Diana [D-CO-1]
Introduced: 2019-05-10
Policy area: Health
Subjects: Digestive and metabolic diseases

Health programs administration and funding

Health promotion and preventive care

Medical research

Research administration and funding

Research and development
Latest action: action_date: 2019-06-04
text: Subcommittee Hearings Held.

Summaries:
action_date: 2019-05-10
action_desc: Introduced in House
text: <p><b>Special Diabetes Program Reauthorization Act of 2019</b></p> <p>This bill reauthorizes through FY2024 the Special Diabetes Program. The program is administered by the National Institutes of Health and focuses on research regarding the prevention and cure of type I diabetes.</p>

tv_txt: I 116th CONGRESS 1st Session H. R. 2668 IN THE HOUSE OF REPRESENTATIVES May 10, 2019 Ms. DeGette (for herself, Mr. Reed , Mr. O'Halleran , and Mr. Mullin ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend section 330B of the Public Health Service Act to reauthorize special programs for Type I diabetes, and for other purposes.

1. Short title This Act may be cited as the Special Diabetes Program Reauthorization Act of 2019 . 2. Reauthorization of special diabetes programs for Type I diabetes Section 330B(b)(2)(D) of the Public Health Service Act ( 42 U.S.C. 254c–2(b)(2)(D) ) is amended after $150,000,000 for each of fiscal years 2018 and 2019 by inserting and $200,000,000 for each of fiscal years 2020 through 2024 .